# Treatment Use of 3,4-Diaminopyridine

> **NCT01765140** · — · NO_LONGER_AVAILABLE · sponsor: **Vern C. Juel, M.D.**

## Conditions studied

- Myasthenic Syndromes, Congenital

## Interventions

- **DRUG:** 3,4-diaminopyridine

## Key facts

- **NCT ID:** NCT01765140
- **Lead sponsor:** Vern C. Juel, M.D.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01765140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01765140, "Treatment Use of 3,4-Diaminopyridine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01765140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*